SEC Form 4 · accession 0001127602-18-036014

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Dec 10, 2018

Accepted (ET)

Dec 12, 2018 · 12:19 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Dec 10, 2018	S	100	$128.65	D	287,648	D
Common Stock	Dec 10, 2018	S	100	$128.80	D	287,548	D
Common Stock	Dec 10, 2018	S	100	$128.84	D	287,448	D
Common Stock	Dec 10, 2018	S	4	$128.98	D	287,444	D
Common Stock	Dec 10, 2018	S	300	$129.02	D	287,144	D
Common Stock	Dec 10, 2018	S	100	$129.10	D	287,044	D
Common Stock	Dec 10, 2018	S	100	$129.11	D	286,944	D
Common Stock	Dec 10, 2018	S	96	$129.145	D	286,848	D
Common Stock	Dec 10, 2018	S	157	$129.15	D	286,691	D
Common Stock	Dec 10, 2018	S	57	$129.16	D	286,634	D
Common Stock	Dec 10, 2018	S	200	$129.17	D	286,434	D
Common Stock	Dec 10, 2018	S	100	$129.19	D	286,334	D
Common Stock	Dec 10, 2018	S	186	$129.20	D	286,148	D
Common Stock	Dec 10, 2018	S	100	$129.22	D	286,048	D
Common Stock	Dec 10, 2018	S	77	$129.235	D	285,971	D
Common Stock	Dec 10, 2018	S	200	$129.43	D	285,771	D
Common Stock	holding	—	—		—	18,390	I	2017 GRAT
Common Stock	holding	—	—		—	340	I	By Trust
Common Stock	holding	—	—		—	10,000	I	Held By Spouse

No Table II lines on this filing.